NCT00088946 2020-07-31
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
Clinical Trials
12 trialsNCT00666562 2017-11-17
Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00676793 2017-09-21
A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression
Louisiana State University Health Sciences Center Shreveport
Phase 2 Completed
NCT00253643 2017-04-18
Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer
OHSU Knight Cancer Institute
Phase NA Completed
NCT00303823 2015-05-05
Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT00459407 2014-10-08
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
National Cancer Institute (NCI)
Phase 1 Completed
NCT00516243 2014-09-12
Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00233935 2014-09-11
Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus
National Cancer Institute (NCI)
Phase 1 Completed
NCT00363805 2013-11-28
Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease
University of Arizona
Phase 2 Completed
NCT00262743 2013-05-30
Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
Mayo Clinic
Phase 1/2 Completed
NCT00676780 2012-08-08
Green Tea Extract and Prostate Cancer
Louisiana State University Health Sciences Center Shreveport
Phase 2 Completed
NCT01082302 2010-09-08
Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage
MediGene
Phase 4 Completed